Molecular Testing of Coronavirus SARS-CoV-2

Patient Information Sample Information

Patient Name KLARA HELENA BLOMB Unique Order ID 6774663
JORD
Date of Birth 08/04/2007 Date of Collection 18/02/2022 - 07:40

Phone 97662842 Date of Receipt 18/02/2022

Email klarahb@outlook.com

Identity 35196022

Result POSITIVE
Genetic material (RNA) of SARS-CoV-2 is detected

Notify your doctor of your results and follow their instructions. Positive
results will be reported by NIPD Genetics to the Ministry of Health.

METHODOLOGY

The NIPD Genetics COVID-19 test is a molecular genetic test for the detection of SARS-CoV-2 which causes
COVID-19. The test checks for the viral RNA signature to confirm the presence of SARS-CoV-2. Viral RNA is
isolated using a standardized methodology and is subjected to Reverse Transcription- quantitative PCR
(RT-qPCR followed by Real-Time PCR Panel) for detection of SARS-CoV-2. The NIPD Genetics molecular
genetic test is specifically designed to detect SARS-CoV-2. It does not detect any other types of coronaviruses.

Approved by: Elena Kypri, Ph.D, ASCP

Approved by: Philippos Patsalis, Ph.D, HCLD, Laboratory Director

Date of report 18/02/2022

Neas Engomis 31, Nicosia, 2409 Cyprus

Phone: +357 22266888 Fax: +357 22266899
Web: www.nipd.com Email: info@nipd.com